As a five-time MMIT Patient Choice Award Winner with a portfolio of 25+ rare programs, PANTHERx attributes much of our success to our ability to hire and cultivate talent while simultaneously investing in state-of-the-art proprietary technology systems. With the expected surge of FDA rare medication approvals over the next decade, talent and technology will become increasingly crucial in order to continue to serve this growing patient population. To successfully complete, pharmacies will be required to adapt and scale their operations, expanding their knowledge and experience while keeping patient care front of mind.
Click here to read our latest article A Best-in-Class Approach from PANTHERx Rare: Harnessing Talent and Technology to Improve Service to Patients Living with Rare Disease as authored by our Trade Relations and Data Analytics Manager, Marissa Puc, Pharm.D.